Literature DB >> 27152737

Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.

Jing-Jing Hu1, Dong Xiao1, Xian-Zheng Zhang1.   

Abstract

During the last decade, using versatile, promising, and fascinating mesoporous silica nanoparticles (MSNs) as site-specific and stimuli-responsive drug delivery systems (DDSs) has received concentrated research interest. As one of the most attractive surface modification units, peptides have inherent bioactivity, biodegradability and biocompatibility. Recent progresses in the utilization of versatile peptides for surface functionalization of MSNs to achieve cell-specific targeting, fluorescence imaging, and intracellular diagnosis and treatment of tumors are summarized in this review. The various functional peptides decorated on the MSNs are introduced and classified into three types, including targeting peptides, stimuli-responsive peptides and multifunctional chimeric peptides. The limitations and challenges of peptide modified MSNs and their potential applications are further discussed.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  drug delivery systems; peptides; silica nanoparticles; stimuli responsive; targets

Mesh:

Substances:

Year:  2016        PMID: 27152737     DOI: 10.1002/smll.201600325

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  9 in total

1.  Light: A Magical Tool for Controlled Drug Delivery.

Authors:  Yu Tao; Hon Fai Chan; Bingyang Shi; Mingqiang Li; Kam W Leong
Journal:  Adv Funct Mater       Date:  2020-09-09       Impact factor: 18.808

Review 2.  Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

Authors:  María Vallet-Regí; Ferdi Schüth; Daniel Lozano; Montserrat Colilla; Miguel Manzano
Journal:  Chem Soc Rev       Date:  2022-07-04       Impact factor: 60.615

Review 3.  Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.

Authors:  Rafael R Castillo; Daniel Lozano; Blanca González; Miguel Manzano; Isabel Izquierdo-Barba; María Vallet-Regí
Journal:  Expert Opin Drug Deliv       Date:  2019-04-22       Impact factor: 6.648

4.  A Space-Time Conversion Vehicle for Programmed Multi-Drugs Delivery into Pancreatic Tumor to Overcome Matrix and Reflux Barriers.

Authors:  Taotao Huo; Xiaoyi Zhang; Min Qian; Huifang Nie; Dong Liang; Chenteng Lin; Yafeng Yang; Wei Guo; Ulrich Lächelt; Rongqin Huang
Journal:  Adv Sci (Weinh)       Date:  2022-05-04       Impact factor: 17.521

Review 5.  Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.

Authors:  Jörgen Elgqvist
Journal:  Int J Mol Sci       Date:  2017-05-20       Impact factor: 5.923

Review 6.  Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment.

Authors:  Eleen Dayana Mohamed Isa; Haslina Ahmad; Mohd Basyaruddin Abdul Rahman; Martin R Gill
Journal:  Pharmaceutics       Date:  2021-01-24       Impact factor: 6.321

Review 7.  Novel Drug and Gene Delivery System and Imaging Agent Based on Marine Diatom Biosilica Nanoparticles.

Authors:  Hanaa Ali Hussein; Muhammad Shahid Nazir; Nizakat Azra; Zeenat Qamar; Azman Seeni; Tengku Ahmad Damitri Al-Astani Tengku Din; Mohd Azmuddin Abdullah
Journal:  Mar Drugs       Date:  2022-07-27       Impact factor: 6.085

8.  TMTP1-Modified, Tumor Microenvironment Responsive Nanoparticles Co-Deliver Cisplatin and Paclitaxel Prodrugs for Effective Cervical Cancer Therapy.

Authors:  Guiying Jiang; Xueqian Wang; Ying Zhou; Chenming Zou; Ling Wang; Wei Wang; Danya Zhang; Hanjie Xu; Jie Li; Fei Li; Danfeng Luo; Xiangyi Ma; Ding Ma; Songwei Tan; Rui Wei; Ling Xi
Journal:  Int J Nanomedicine       Date:  2021-06-15

Review 9.  Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules.

Authors:  Rafael R Castillo; Daniel Lozano; María Vallet-Regí
Journal:  Pharmaceutics       Date:  2020-05-07       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.